Search

everythinglearnresearchcommunity

for

Search:↓

Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

The combination of Stemoxydine® and Resveratrol improves hair density in women with Female Pattern Hair Loss.

Different enzymes are active in different parts of developing mouse organs.

Stevioside-based microneedles improve minoxidil delivery for effective hair growth treatment.

Stevioside-based microneedles improve minoxidil delivery and hair growth for treating hair loss.

The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

A mutation in the vitamin D receptor causes severe resistance to vitamin D, affecting bone health but not hair growth.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Human liver enzyme DHEA ST helps process minoxidil.

Oral etretinate improved hair length and reduced beading in monilethrix.

Minoxidil, caffeine, and biotin can improve hair shine by restoring certain genes.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

Estetrol helps keep scalp hair in the growth phase longer and improves hair follicle health by affecting the hair root and increasing stem cells.

5% topical minoxidil improves hair density and quality in monilethrix patients.